• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型绿色胶束 HPLC-UV 法用于纯品、人尿、人血浆和人肝微粒体基质中凡德他尼的测定及其在代谢稳定性评价中的应用。

A Novel Green Micellar HPLC-UV Method for the Estimation of Vandetanib in Pure Form, Human Urine, Human Plasma and Human Liver Microsomes Matrices with Application to Metabolic Stability Evaluation.

机构信息

Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.

Students' University Hospital, Mansoura University, Mansoura 35516, Egypt.

出版信息

Molecules. 2022 Dec 18;27(24):9038. doi: 10.3390/molecules27249038.

DOI:10.3390/molecules27249038
PMID:36558172
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9783097/
Abstract

Vandetanib (Caprelsa; VNB) is a prescription medicine that is used for the treatment of medullary thyroid cancer that has disrupted other body parts or that cannot be removed by surgery. It is considered a tyrosine kinase inhibitor (TKI). Fast, sensitive and validated HPLC-UV was established for VNB quantification in pure human biological fluids (urine and plasma) and human liver microsomes (HLMs). This analytical methodology was applied also to the metabolic stability assessment of VNB. This method was performed using a phenyl column (250 mm × 4.6 mm id, 5 µm particle size). A sodium dodecyl sulphate solution (0.05 M, pH 3.0 using 0.02 M orthophosphoric acid) containing 0.3% triethylamine and 10% n-butanol was used as a mobile phase and was pumped isocratically at a flow rate of 0.7 mL/min and at a 260 nm detection wavelength. The total elution time was 6 min with an injection volume of 20 μL. The linearity of the established methodology ranged from 30 to 500 ng/mL in pure form and 50 to 500 ng/mL (r ≥ 0.9994) in human biological fluids and HLMs. No significant interference from the matrix components was observed. The proposed methodology revealed the benefits of being green, reliable and economic.

摘要

凡德他尼(Caprelsa;VNB)是一种处方药物,用于治疗已经扩散到身体其他部位或无法通过手术切除的甲状腺髓样癌。它被认为是一种酪氨酸激酶抑制剂(TKI)。建立了快速、灵敏和经过验证的 HPLC-UV 法,用于纯人体生物流体(尿液和血浆)和人肝微粒体(HLMs)中 VNB 的定量。该分析方法也应用于 VNB 的代谢稳定性评估。该方法使用苯基柱(250mm×4.6mm id,5µm 粒径)进行。含有 0.3%三乙胺和 10%正丁醇的十二烷基硫酸钠溶液(0.05M,使用 0.02M 正磷酸调至 pH3.0)用作流动相,并以 0.7mL/min 的流速等度泵出,检测波长为 260nm。总洗脱时间为 6 分钟,进样量为 20μL。建立的方法在纯品中的线性范围为 30-500ng/mL,在人体生物流体和 HLMs 中的线性范围为 50-500ng/mL(r≥0.9994)。未观察到基质成分的显著干扰。所提出的方法具有绿色、可靠和经济的优点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8072/9783097/5b7f4c4a3735/molecules-27-09038-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8072/9783097/d0f7dc621891/molecules-27-09038-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8072/9783097/dd9800cb1012/molecules-27-09038-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8072/9783097/5b7f4c4a3735/molecules-27-09038-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8072/9783097/d0f7dc621891/molecules-27-09038-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8072/9783097/dd9800cb1012/molecules-27-09038-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8072/9783097/5b7f4c4a3735/molecules-27-09038-g003.jpg

相似文献

1
A Novel Green Micellar HPLC-UV Method for the Estimation of Vandetanib in Pure Form, Human Urine, Human Plasma and Human Liver Microsomes Matrices with Application to Metabolic Stability Evaluation.一种新型绿色胶束 HPLC-UV 法用于纯品、人尿、人血浆和人肝微粒体基质中凡德他尼的测定及其在代谢稳定性评价中的应用。
Molecules. 2022 Dec 18;27(24):9038. doi: 10.3390/molecules27249038.
2
Investigation of anti-Hepatitis C virus, sofosbuvir and daclatasvir, in pure form, human plasma and human urine using micellar monolithic HPLC-UV method and application to pharmacokinetic study.采用胶束整体 HPLC-UV 法研究单纯形式、人血浆和人尿中的抗丙型肝炎病毒药物索非布韦和达卡他韦,并将其应用于药代动力学研究。
J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Jun 1;1086:73-81. doi: 10.1016/j.jchromb.2018.04.011. Epub 2018 Apr 7.
3
Micellar HPLC method for the simultaneous determination of three anticonvulsant drugs in dosage forms and biological fluids. Application to dissolution-rate testing.胶束高效液相色谱法同时测定剂型和生物流体中的三种抗惊厥药物。应用于溶出度测试。
Ann Pharm Fr. 2018 May;76(3):172-186. doi: 10.1016/j.pharma.2018.02.003. Epub 2018 Mar 22.
4
Liquid chromatography tandem mass spectrometry method for the quantification of vandetanib in human plasma and rat liver microsomes matrices: metabolic stability investigation.液相色谱串联质谱法测定人血浆和大鼠肝微粒体基质中凡德他尼的含量:代谢稳定性研究
Chem Cent J. 2017 May 30;11(1):45. doi: 10.1186/s13065-017-0274-4.
5
Green micellar liquid chromatographic analysis of alfuzosin hydrochloride and sildenafil citrate in a binary mixture compared to classical RPLC with stability indicating studies.绿胶束液相色谱法分析盐酸阿夫唑嗪和西地那非枸橼酸盐的二元混合物与具有稳定性指示研究的经典反相高效液相色谱法的比较。
Drug Dev Ind Pharm. 2022 Feb;48(2):41-51. doi: 10.1080/03639045.2022.2093896. Epub 2022 Jul 8.
6
Development and validation of a micellar high-performance liquid chromatographic method for determination of risedronate in raw material and in a pharmaceutical formulation: application to stability studies.一种用于测定原料及药物制剂中利塞膦酸盐的胶束高效液相色谱法的开发与验证:在稳定性研究中的应用
J AOAC Int. 2010 Jul-Aug;93(4):1228-35.
7
Development and validation of an HPLC-MS/MS method for the determination of filgotinib, a selective Janus kinase 1 inhibitor: Application to a metabolic stability study.建立并验证 HPLC-MS/MS 法测定选择性 Janus 激酶 1 抑制剂 filgotinib:应用于代谢稳定性研究。
J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Oct 1;1154:122195. doi: 10.1016/j.jchromb.2020.122195. Epub 2020 May 30.
8
Green analytical chromatographic assay method for quantitation of cyclobenzaprine in tablets, spiked human urine and in-vitro dissolution test.用于定量测定片剂、加标人尿中的环苯扎林以及体外溶出试验的绿色分析色谱测定法。
Ann Pharm Fr. 2019 Sep;77(5):418-425. doi: 10.1016/j.pharma.2019.06.004. Epub 2019 Jul 9.
9
Micellar high performance liquid chromatographic method for separation and validation of two anti-hepatitis C- virus drugs in pure form, human plasma and human urine.胶束高效液相色谱法分离和纯品、人血浆和人尿中两种抗丙型肝炎病毒药物的验证。
Ann Pharm Fr. 2020 May;78(3):217-229. doi: 10.1016/j.pharma.2020.01.007. Epub 2020 Feb 9.
10
Derivative Quotient Spectrophotometry and an Eco-Friendly Micellar Chromatographic Approach with Time-Programmed UV-Detection for the Separation of Two Fluoroquinolones and Phenazopyridine.导数商分光光度法及一种采用程序控时紫外检测的环保型胶束色谱法用于两种氟喹诺酮类药物和非那吡啶的分离
J Chromatogr Sci. 2016 May-Jun;54(5):776-89. doi: 10.1093/chromsci/bmw010. Epub 2016 Feb 10.

本文引用的文献

1
Identification and characterization of , , , and reactive metabolites of infigratinib using LC-ITMS: bioactivation pathway elucidation and toxicity studies of its metabolites.使用液相色谱-离子阱质谱联用技术鉴定和表征英菲格拉替尼的、、、及反应性代谢产物:生物活化途径阐释及其代谢产物的毒性研究
RSC Adv. 2020 Apr 23;10(28):16231-16244. doi: 10.1039/c9ra10871h.
2
Development of novel univariate and multivariate validated chemometric methods for the analysis of dasatinib, sorafenib, and vandetanib in pure form, dosage forms and biological fluids.开发新的单变量和多变量验证化学计量学方法,用于分析纯品、制剂和生物体液中的达沙替尼、索拉非尼和凡德他尼。
Spectrochim Acta A Mol Biomol Spectrosc. 2022 Jan 5;264:120336. doi: 10.1016/j.saa.2021.120336. Epub 2021 Aug 28.
3
Simple and efficient spectroscopic-based univariate sequential methods for simultaneous quantitative analysis of vandetanib, dasatinib, and sorafenib in pharmaceutical preparations and biological fluids.基于光谱的简单高效单变量序贯法用于同时定量分析药物制剂和生物体液中的凡德他尼、达沙替尼和索拉非尼。
Spectrochim Acta A Mol Biomol Spectrosc. 2021 Nov 5;260:119987. doi: 10.1016/j.saa.2021.119987. Epub 2021 May 21.
4
Metabolic Stability Assessment of New PARP Inhibitor Talazoparib Using Validated LC-MS/MS Methodology: In silico Metabolic Vulnerability and Toxicity Studies.采用经验证的 LC-MS/MS 方法评估新型 PARP 抑制剂他拉唑帕尼的代谢稳定性:基于计算的代谢脆弱性和毒理学研究。
Drug Des Devel Ther. 2020 Feb 25;14:783-793. doi: 10.2147/DDDT.S239458. eCollection 2020.
5
A highly sensitive LC-MS/MS method to determine novel Bruton's tyrosine kinase inhibitor spebrutinib: application to metabolic stability evaluation.一种用于测定新型布鲁顿酪氨酸激酶抑制剂司布替尼的高灵敏度液相色谱-串联质谱法:在代谢稳定性评估中的应用
R Soc Open Sci. 2019 Jun 5;6(6):190434. doi: 10.1098/rsos.190434. eCollection 2019 Jun.
6
Investigation of metabolic degradation of new ALK inhibitor: Entrectinib by LC-MS/MS.运用 LC-MS/MS 技术对新型 ALK 抑制剂(Entrectinib)的代谢降解进行研究。
Clin Chim Acta. 2018 Oct;485:298-304. doi: 10.1016/j.cca.2018.07.009. Epub 2018 Jul 10.
7
A reliable and stable method for the determination of foretinib in human plasma by LC-MS/MS: Application to metabolic stability investigation and excretion rate.一种通过液相色谱-串联质谱法测定人血浆中福瑞替尼的可靠且稳定的方法:在代谢稳定性研究和排泄率中的应用。
Eur J Mass Spectrom (Chichester). 2018 Aug;24(4):344-351. doi: 10.1177/1469066718768327. Epub 2018 Apr 8.
8
Micellar HPLC method for the simultaneous determination of three anticonvulsant drugs in dosage forms and biological fluids. Application to dissolution-rate testing.胶束高效液相色谱法同时测定剂型和生物流体中的三种抗惊厥药物。应用于溶出度测试。
Ann Pharm Fr. 2018 May;76(3):172-186. doi: 10.1016/j.pharma.2018.02.003. Epub 2018 Mar 22.
9
Investigation of metabolic stability of the novel ALK inhibitor brigatinib by liquid chromatography tandem mass spectrometry.采用液相色谱-串联质谱法研究新型 ALK 抑制剂布加替尼的代谢稳定性。
Clin Chim Acta. 2018 May;480:180-185. doi: 10.1016/j.cca.2018.02.016. Epub 2018 Feb 16.
10
LC-MS/MS method for the quantification of masitinib in RLMs matrix and rat urine: application to metabolic stability and excretion rate.用于定量测定微粒体(RLMs)基质和大鼠尿液中马西替尼的液相色谱-串联质谱(LC-MS/MS)方法:在代谢稳定性和排泄率方面的应用
Chem Cent J. 2017 Dec 22;11(1):136. doi: 10.1186/s13065-017-0365-2.